New York, NY – July 2023 – OCLI Vision is delighted to announce that Dr. Eric Donnenfeld, Dr. Richard Mackool, Dr. Marguerite McDonald, and Dr. Henry Perry have all once again been recognized on Newsweek’s America’s Best Eye Doctors 2023 list. This marks the third consecutive year that Dr. Donnenfeld, a nationally and internationally acclaimed ophthalmologist, is named in this annual ranking as the top ophthalmologist in the country.
Newsweek’s prestigious list recognizes the top 175 ophthalmologists and optometrists in the United States. Doctors are ranked based on their commitment to providing high-quality service, maintaining continuity of care, and employing state-of-the-art technology in their practices. These rankings are compiled through surveys of thousands of ophthalmologists, optometrists, clinic managers, and other healthcare professionals across the country.
“The consistent recognition on Newsweek’s list affirms the exceptional quality of care all of these doctors deliver to their patients,” commented Tom Burke, CEO of Spectrum Vision Partners. “Their tireless dedication, coupled with their unwavering commitment to advancing the field of ophthalmology, aligns seamlessly with OCLI Vision’s mission to provide top-tier eye care services. All of us at OCLI Vision send our most heartfelt congratulations to Dr. Donnenfeld, Dr. Mackool, Dr. McDonald, and Dr. Perry.”
Recognized as Newsweek’s best ophthalmologist in the country for three consecutive years (2021-2023), Dr. Eric D. Donnenfeld continues to display an exceptional level of care and innovative use of technology in his practice. Renowned as an international expert and pioneer in refractive, cornea, and cataract surgery, Dr. Donnenfeld is among the leading refractive and cataract surgeons in the United States. Notably, he has served as President of the American Society of Cataract and Refractive Surgery, and holds key positions in ophthalmology, and Surgical Director of the Lions Eye Bank for Long Island. Dr. Donnenfeld was awarded the American Society of Cataract and Refractive Surgery, (ASCRS) Cornelius Binkhorst, MD, Lecture and Medal this year. Each year, ASCRS awards the medal to an individual who has followed in Dr. Binkhorst’s footsteps with outstanding contributions to the understanding and practice of anterior segment surgery.
Dr. Richard J. Mackool, a distinguished ophthalmologist and the founder and Director of The Mackool Eye Institute and Laser Center in Queens, is once again on Newsweek’s America’s Best Eye Doctors list. His practice, the first of its kind in New York to offer eye surgery and laser treatment without hospitalization, has been at the forefront of ophthalmology since its inception in 1973. Dr. Mackool has made significant contributions to microsurgery of the eye. He has published numerous scientific papers and textbooks and is renowned for his courses that attract eye surgeons worldwide.
Dr. Marguerite McDonald, a distinguished ophthalmologist and pioneer in refractive surgery, has been named in Newsweek’s America’s Best Eye Doctors 2023 list for the third year in a row. Renowned for her pioneering work in refractive surgery, including the development and implementation of the first excimer laser procedure, Dr. McDonald’s research has significantly advanced the field. She has been recognized with over 90 professional awards for her groundbreaking work and contributes actively to several clinical and scientific journals. This year she was inducted into the American Society of Cataract and Refractive Surgery (ASCRS) Ophthalmology Hall of Fame.
Dr. Perry’s inclusion in this list is a testament to his exceptional skills, dedication, and contributions to the field of corneal and refractive surgery. As a board-certified ophthalmologist, Dr. Perry is one of the leading corneal and refractive surgeons in the country. His expertise extends globally, with international lectures to his credit. His efforts have earned him a series of accolades, including the Senior Honor Award and Honor Award from the American Academy of Ophthalmology.
OCLI Vision is a premier ophthalmology practice that continues to grow and excel, supported by Spectrum Vision Partners’ management and administrative services. Spectrum Vision Partners serves top ophthalmology groups and ambulatory eye surgery centers across New York, New Jersey, Connecticut, Pennsylvania, and West Virginia.
For more information about OCLI Vision and Spectrum Vision Partners, please contact:
Chief Executive Officer
Chief Development Officer
About OCLI Vision
Founded in 1997, OCLI Vision (www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
About Spectrum Vision Partners
Spectrum Vision Partners (SVP) (www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With over 1,400 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 50 clinic locations, 5 state-licensed ambulatory surgery centers, and over 150 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.
About Blue Sea Capital
Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies with EBITDA of up to $30 million. The firm has over $1.3 billion in committed capital and invests across three industry verticals: aerospace & defense, healthcare and industrial growth. Blue Sea Capital’s strategy is to partner with talented leaders and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.